{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:50:50Z","timestamp":1790985050541,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01587-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:35:31Z","timestamp":1776447331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-3376","authenticated-orcid":false,"given":"Ferdinand W.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad J. M.","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8136-4289","authenticated-orcid":false,"given":"Puck B.","family":"Gouswaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-9971","authenticated-orcid":false,"given":"Lennart A.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8580-4822","authenticated-orcid":false,"given":"Thomas F.","family":"Eleveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8146-1911","authenticated-orcid":false,"given":"Leendert H. J.","family":"Looijenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1587_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","volume":"19","author":"JW Oosterhuis","year":"2019","unstructured":"Oosterhuis, J. W. & Looijenga, L. H. J. Human germ cell tumours from a developmental perspective. Nat. Rev. Cancer 19, 522\u2013537 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1587_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.mpdhp.2023.03.001","volume":"29","author":"I Kilic","year":"2023","unstructured":"Kilic, I. & Idrees, M. T. The 2022 World Health Organization classification of germ cell tumors and updates of American Joint Committee for Cancer tumor staging classification. Diagn. Histopathol. 29, 259\u2013268 (2023).","journal-title":"Diagn. Histopathol."},{"key":"1587_CR3","doi-asserted-by":"crossref","unstructured":"Giona, S. The epidemiology of testicular cancer. In Urologic Cancers (Exon Publications, 2022).","DOI":"10.36255\/exon-publications-urologic-cancers-epidemiology-testicular-cancer"},{"key":"1587_CR4","first-page":"133","volume":"17","author":"S Aminimoghaddam","year":"2016","unstructured":"Aminimoghaddam, S. et al. Ovarian malignant mixed germ cell tumor: a case of unusual presentation as molar pregnancy. J. Reprod. Infertil. 17, 133\u2013136 (2016).","journal-title":"J. Reprod. Infertil."},{"key":"1587_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/1793-5482.106652","volume":"7","author":"ST Mufti","year":"2012","unstructured":"Mufti, S. T. & Jamal, A. Primary intracranial germ cell tumors. Asian J. Neurosurg. 7, 197\u2013202 (2012).","journal-title":"Asian J. Neurosurg."},{"key":"1587_CR6","doi-asserted-by":"crossref","unstructured":"International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J. Clin. Oncol. 15, 594\u2013603 (1997).","DOI":"10.1200\/JCO.1997.15.2.594"},{"key":"1587_CR7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1200\/JCO.20.03296","volume":"39","author":"S Gillessen","year":"2021","unstructured":"Gillessen, S. et al. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium. J. Clin. Oncol. 39, 1563\u20131574 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1587_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","volume":"33","author":"J Oldenburg","year":"2022","unstructured":"Oldenburg, J. et al. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 362\u2013375 (2022).","journal-title":"Ann. Oncol."},{"key":"1587_CR9","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1200\/JCO.21.02809","volume":"40","author":"DM Timmerman","year":"2022","unstructured":"Timmerman, D. M. et al. Chromosome 3p25.3 gain is associated with cisplatin resistance and is an independent predictor of poor outcome in male malignant germ cell tumors. J. Clin. Oncol. 40, 3077\u20133087 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1587_CR10","unstructured":"PDQ\u00ae Adult Treatment Editorial Board. PDQ Testicular Cancer Treatment (National Cancer Institute, 2025); https:\/\/www.cancer.gov\/types\/testicular\/hp\/testicular-treatment-pdq."},{"key":"1587_CR11","doi-asserted-by":"crossref","unstructured":"Berney, D. M., et al. An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology 81, 459\u2013466 (2022).","DOI":"10.1111\/his.14675"},{"key":"1587_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/his.15249","volume":"85","author":"A Fichtner","year":"2024","unstructured":"Fichtner, A., Nettersheim, D. & Bremmer, F. Pathogenesis and pathobiology of testicular germ cell tumours: a view from a developmental biological perspective with guidelines for pathological diagnostics. Histopathology 85, 701\u2013715 (2024).","journal-title":"Histopathology"},{"key":"1587_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00657-z","volume":"8","author":"FW Janssen","year":"2024","unstructured":"Janssen, F. W. et al. A comprehensive overview of liquid biopsy applications in pediatric solid tumors. NPJ Precis Oncol. 8, 172 (2024).","journal-title":"NPJ Precis Oncol."},{"key":"1587_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct. Target Ther. 9, 336 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"1587_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ucl.2022.09.002","volume":"50","author":"J Egan","year":"2023","unstructured":"Egan, J. & Salari, K. Biomarkers in testicular cancer: classic tumor markers and beyond. Urol. Clin. North Am. 50, 133\u2013143 (2023).","journal-title":"Urol. Clin. North Am."},{"key":"1587_CR16","doi-asserted-by":"publisher","first-page":"103224","DOI":"10.1016\/j.critrevonc.2021.103224","volume":"159","author":"P Pedrazzoli","year":"2021","unstructured":"Pedrazzoli, P. et al. Serum tumour markers in germ cell tumours: from diagnosis to cure. Crit. Rev. Oncol. Hematol. 159, 103224 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1587_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.canep.2019.01.001","volume":"59","author":"BD Nicholson","year":"2019","unstructured":"Nicholson, B. D. et al. The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: a diagnostic test accuracy systematic review. Cancer Epidemiol. 59, 15\u201321 (2019).","journal-title":"Cancer Epidemiol."},{"key":"1587_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","volume":"124","author":"PM Voorhoeve","year":"2006","unstructured":"Voorhoeve, P. M. et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169\u20131181 (2006).","journal-title":"Cell"},{"key":"1587_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","volume":"80","author":"R Leao","year":"2021","unstructured":"Leao, R. et al. Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review. Eur. Urol. 80, 456\u2013466 (2021).","journal-title":"Eur. Urol."},{"key":"1587_CR20","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","volume":"23","author":"H Shen","year":"2018","unstructured":"Shen, H. et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 23, 3392\u20133406 (2018).","journal-title":"Cell Rep."},{"key":"1587_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00401-016-1557-x","volume":"131","author":"K Ichimura","year":"2016","unstructured":"Ichimura, K. et al. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy. Acta Neuropathol. 131, 889\u2013901 (2016).","journal-title":"Acta Neuropathol."},{"key":"1587_CR22","doi-asserted-by":"crossref","unstructured":"Nicu, A. T. et al. Recent advancements in research on DNA methylation and testicular germ cell tumors: unveiling the intricate relationship. Biomedicines 12, 1041 (2024).","DOI":"10.3390\/biomedicines12051041"},{"key":"1587_CR23","doi-asserted-by":"publisher","first-page":"861995","DOI":"10.3389\/fcell.2022.861995","volume":"10","author":"AT Nicu","year":"2022","unstructured":"Nicu, A. T. et al. Epigenetics and testicular cancer: bridging the gap between fundamental biology and patient care. Front. Cell Dev. Biol. 10, 861995 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1587_CR24","doi-asserted-by":"crossref","unstructured":"Singh, R. et al. Between a rock and a hard place: an epigenetic-centric view of testicular germ cell tumors. Cancers 13, 1506 (2021).","DOI":"10.3390\/cancers13071506"},{"key":"1587_CR25","doi-asserted-by":"crossref","unstructured":"Lobo, J. et al. Combining hypermethylated RASSF1A detection using ddPCR with miR-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients. Cancers 13, 5228 (2021).","DOI":"10.3390\/cancers13205228"},{"key":"1587_CR26","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gr.201293.115","volume":"26","author":"JK Killian","year":"2016","unstructured":"Killian, J. K. et al. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res. 26, 1490\u20131504 (2016).","journal-title":"Genome Res."},{"key":"1587_CR27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2217\/epi-2018-0034","volume":"10","author":"AL Costa","year":"2018","unstructured":"Costa, A. L. et al. DNA methylation profiling as a tool for testicular germ cell tumors subtyping. Epigenomics 10, 1511\u20131523 (2018).","journal-title":"Epigenomics"},{"key":"1587_CR28","doi-asserted-by":"crossref","unstructured":"Lobo, J. et al. XIST-promoter demethylation as tissue biomarker for testicular germ cell tumors and spermatogenesis quality. Cancers 11, 1385 (2019).","DOI":"10.3390\/cancers11091385"},{"key":"1587_CR29","doi-asserted-by":"publisher","first-page":"e0122146","DOI":"10.1371\/journal.pone.0122146","volume":"10","author":"MA Rijlaarsdam","year":"2015","unstructured":"Rijlaarsdam, M. A. et al. Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors. PLoS One 10, e0122146 (2015).","journal-title":"PLoS One"},{"key":"1587_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01048-y","volume":"13","author":"J Lobo","year":"2021","unstructured":"Lobo, J. et al. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples. Clin. Epigenetics 13, 70 (2021).","journal-title":"Clin. Epigenetics"},{"key":"1587_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13000-020-01011-0","volume":"15","author":"MEG Kranendonk","year":"2020","unstructured":"Kranendonk, M. E. G. et al. The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: report of 2 cases. Diagn. Pathol. 15, 99 (2020).","journal-title":"Diagn. Pathol."},{"key":"1587_CR32","doi-asserted-by":"crossref","unstructured":"Timmerman, D.M. et al. The role of TP53 in cisplatin resistance in mediastinal and testicular germ cell tumors. Int. J. Mol. Sci. 22, 11774 (2021).","DOI":"10.3390\/ijms222111774"},{"key":"1587_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01458-7","volume":"20","author":"S Schmidtova","year":"2020","unstructured":"Schmidtova, S. et al. Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness. Cancer Cell Int. 20, 364 (2020).","journal-title":"Cancer Cell Int."},{"key":"1587_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3892\/ol.2022.13512","volume":"24","author":"S Schmidtova","year":"2022","unstructured":"Schmidtova, S. et al. Effect of the PARP inhibitor veliparib on germ cell tumor cell lines. Oncol. Lett. 24, 392 (2022).","journal-title":"Oncol. Lett."},{"key":"1587_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"1587_CR36","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"1587_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-293","volume":"14","author":"R Pidsley","year":"2013","unstructured":"Pidsley, R. et al. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 14, 293 (2013).","journal-title":"BMC Genomics"},{"key":"1587_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0503-2","volume":"15","author":"JP Fortin","year":"2014","unstructured":"Fortin, J. P. et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 15, 503 (2014).","journal-title":"Genome Biol."},{"key":"1587_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-8935-8-6","volume":"8","author":"TJ Peters","year":"2015","unstructured":"Peters, T. J. et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin 8, 6 (2015).","journal-title":"Epigenetics Chromatin"},{"key":"1587_CR40","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s42003-020-01146-2","volume":"3","author":"D Arneson","year":"2020","unstructured":"Arneson, D., Yang, X. & Wang, K. MethylResolver\u2014a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents. Commun. Biol. 3, 422 (2020).","journal-title":"Commun. Biol."},{"key":"1587_CR41","doi-asserted-by":"crossref","unstructured":"McInnes, L. et al. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","DOI":"10.21105\/joss.00861"},{"key":"1587_CR42","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"1587_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-1-4939-7481-8_21","volume":"1708","author":"G Beikircher","year":"2018","unstructured":"Beikircher, G. et al. Multiplexed and sensitive DNA methylation testing using methylation-sensitive restriction enzymes \u201cMSRE-qPCR\u201d. Methods Mol. Biol. 1708, 407\u2013424 (2018).","journal-title":"Methods Mol. Biol."},{"key":"1587_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-019-0107-z","volume":"21","author":"S Sestakova","year":"2019","unstructured":"Sestakova, S., Salek, C. & Remesova, H. DNA methylation validation methods: a coherent review with practical comparison. Biol. Proced. Online 21, 19 (2019).","journal-title":"Biol. Proced. Online"},{"key":"1587_CR45","doi-asserted-by":"publisher","unstructured":"Janssen. Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypes. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.19006095 (2026).","DOI":"10.5281\/zenodo.19006095"},{"key":"1587_CR46","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson, N. M. & Simon, M. C. The tumor microenvironment. Curr. Biol. 30, R921\u2013R925 (2020).","journal-title":"Curr. Biol."},{"key":"1587_CR47","doi-asserted-by":"publisher","first-page":"e0265557","DOI":"10.1371\/journal.pone.0265557","volume":"17","author":"J Staaf","year":"2022","unstructured":"Staaf, J. & Aine, M. Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data. PLoS One 17, e0265557 (2022).","journal-title":"PLoS One"},{"key":"1587_CR48","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/S0959-8049(02)00235-6","volume":"38","author":"C Parker","year":"2002","unstructured":"Parker, C. et al. The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur. J. Cancer 38, 2014\u20132019 (2002).","journal-title":"Eur. J. Cancer"},{"key":"1587_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jri.2013.10.005","volume":"100","author":"T Hvarness","year":"2013","unstructured":"Hvarness, T. et al. Phenotypic characterisation of immune cell infiltrates in testicular germ cell neoplasia. J. Reprod. Immunol. 100, 135\u2013145 (2013).","journal-title":"J. Reprod. Immunol."},{"key":"1587_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3171\/jns.1989.70.1.0081","volume":"70","author":"T Saito","year":"1989","unstructured":"Saito, T. et al. Tumor-infiltrating lymphocytes and histocompatibility antigens in primary intracranial germinomas. J. Neurosurg. 70, 81\u201385 (1989).","journal-title":"J. Neurosurg."},{"key":"1587_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/nan.12570","volume":"46","author":"H Takami","year":"2020","unstructured":"Takami, H. et al. Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance. Neuropathol. Appl. Neurobiol. 46, 111\u2013124 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1587_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.mpdhp.2020.03.006","volume":"26","author":"B Kaur","year":"2020","unstructured":"Kaur, B. Pathology of malignant ovarian germ cell tumours. Diagn. Histopathol. 26, 289\u2013297 (2020).","journal-title":"Diagn. Histopathol."},{"key":"1587_CR53","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s42003-020-01267-8","volume":"3","author":"Y Kubota","year":"2020","unstructured":"Kubota, Y. et al. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets. Commun. Biol. 3, 544 (2020).","journal-title":"Commun. Biol."},{"key":"1587_CR54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41416-018-0277-5","volume":"119","author":"LA Williams","year":"2018","unstructured":"Williams, L. A. et al. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children\u2019s Oncology Group. Br. J. Cancer 119, 864\u2013872 (2018).","journal-title":"Br. J. Cancer"},{"key":"1587_CR55","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-017-1673-2","volume":"133","author":"S Fukushima","year":"2017","unstructured":"Fukushima, S. et al. Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathol. 133, 445\u2013462 (2017).","journal-title":"Acta Neuropathol."},{"key":"1587_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajpath.2011.03.022","volume":"179","author":"JK Killian","year":"2011","unstructured":"Killian, J. K. et al. A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology. Am. J. Pathol. 179, 55\u201365 (2011).","journal-title":"Am. J. Pathol."},{"key":"1587_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75586-9","volume":"14","author":"S Zhou","year":"2024","unstructured":"Zhou, S. et al. Exploring the correlation between DNA methylation and biological age using an interpretable machine learning framework. Sci. Rep. 14, 24208 (2024).","journal-title":"Sci. Rep."},{"key":"1587_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/his.14933","volume":"83","author":"F Bremmer","year":"2023","unstructured":"Bremmer, F. et al. Updating germ cell tumour pathogenesis - the ability of seminomas for FOXA2-driven extra-embryonic differentiation. Histopathology 83, 477\u2013481 (2023).","journal-title":"Histopathology"},{"key":"1587_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/path.6412","volume":"266","author":"J Lobo","year":"2025","unstructured":"Lobo, J. et al. MicroRNA-371-373 cluster and methylome analysis suggests that a subset of \u2018somatic-type\u2019 malignancies arising in germ cell tumors may originate in yolk sac tumor components. J. Pathol. 266, 160\u2013176 (2025).","journal-title":"J. Pathol."},{"key":"1587_CR60","doi-asserted-by":"publisher","first-page":"1327724","DOI":"10.3389\/fonc.2023.1327724","volume":"13","author":"S Li","year":"2023","unstructured":"Li, S. et al. Subsequent ovarian yolk sac tumor after operation of ovarian mature teratoma: a case report and review of the literature. Front Oncol. 13, 1327724 (2023).","journal-title":"Front Oncol."},{"key":"1587_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"SK Corbacioglu","year":"2023","unstructured":"Corbacioglu, S. K. & Aksel, G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turk. J. Emerg. Med. 23, 195\u2013198 (2023).","journal-title":"Turk. J. Emerg. Med."},{"key":"1587_CR62","doi-asserted-by":"publisher","first-page":"D1004","DOI":"10.1093\/nar\/gkab972","volume":"50","author":"Z Xiong","year":"2022","unstructured":"Xiong, Z. et al. EWAS Open Platform: integrated data, knowledge and toolkit for epigenome-wide association study. Nucleic Acids Res. 50, D1004\u2013D1009 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1587_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan, J. C. M. et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer 17, 223\u2013238 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"1587_CR64","doi-asserted-by":"publisher","first-page":"653222","DOI":"10.3389\/fonc.2021.653222","volume":"11","author":"L Zhu","year":"2021","unstructured":"Zhu, L. et al. APC promoter methylation in gastrointestinal cancer. Front. Oncol. 11, 653222 (2021).","journal-title":"Front. Oncol."},{"key":"1587_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21192-3","volume":"25","author":"J Jiang","year":"2025","unstructured":"Jiang, J. et al. Epidemiological trends in gastrointestinal cancers and risk factors across U.S. states from 2000 to 2021: a systematic analysis for the global burden of disease study 2021. BMC Public Health 25, 43 (2025).","journal-title":"BMC Public Health"},{"key":"1587_CR66","doi-asserted-by":"crossref","unstructured":"Yodkhunnatham, N. et al. MicroRNAs in testicular germ cell tumors: the teratoma challenge. Int. J. Mol. Sci. 25, 2156 (2024).","DOI":"10.3390\/ijms25042156"},{"key":"1587_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2017.06.006","volume":"533","author":"CJ Petell","year":"2017","unstructured":"Petell, C. J. et al. A refined DNA methylation detection method using MspJI coupled quantitative PCR. Anal. Biochem. 533, 1\u20139 (2017).","journal-title":"Anal. Biochem."},{"key":"1587_CR68","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/pd.6774","volume":"45","author":"R Dannebaum","year":"2025","unstructured":"Dannebaum, R. et al. Digital PCR assay utilizing in-droplet methylation-sensitive digestion for estimation of fetal cfDNA from plasma. Prenat. Diagn. 45, 500\u2013509 (2025).","journal-title":"Prenat. Diagn."},{"key":"1587_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59899-z","volume":"10","author":"TW Parker","year":"2020","unstructured":"Parker, T. W. & Neufeld, K. L. APC controls Wnt-induced beta-catenin destruction complex recruitment in human colonocytes. Sci. Rep. 10, 2957 (2020).","journal-title":"Sci. Rep."},{"key":"1587_CR70","doi-asserted-by":"crossref","unstructured":"van Soest, M. et al. Yolk sac elements in tumors derived from pluripotent stem cells: borrowing knowledge from human germ cell tumors. Int. J. Mol. Sci. 26, 6464 (2025).","DOI":"10.3390\/ijms26136464"},{"key":"1587_CR71","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1038\/sj.onc.1205599","volume":"21","author":"MS Turker","year":"2002","unstructured":"Turker, M. S. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21, 5388\u20135393 (2002).","journal-title":"Oncogene"},{"key":"1587_CR72","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/pbc.22669","volume":"56","author":"V Okpanyi","year":"2011","unstructured":"Okpanyi, V. et al. Analysis of the adenomatous polyposis coli (APC) gene in childhood and adolescent germ cell tumors. Pediatr. Blood Cancer 56, 384\u2013391 (2011).","journal-title":"Pediatr. Blood Cancer"},{"key":"1587_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38378-9","volume":"14","author":"L Xu","year":"2023","unstructured":"Xu, L. et al. Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nat. Commun. 14, 2636 (2023).","journal-title":"Nat. Commun."},{"key":"1587_CR74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.humpath.2005.09.008","volume":"37","author":"N Kato","year":"2006","unstructured":"Kato, N. et al. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants. Hum. Pathol. 37, 48\u201353 (2006).","journal-title":"Hum. Pathol."},{"key":"1587_CR75","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/10668969211069963","volume":"30","author":"T Otani","year":"2022","unstructured":"Otani, T. et al. Yolk sac tumor in a recurrence of colonic adenocarcinoma with shared mutations in APC and TP53 genes: a case report. Int. J. Surg. Pathol. 30, 646\u2013651 (2022).","journal-title":"Int. J. Surg. Pathol."},{"key":"1587_CR76","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/bjc.2011.218","volume":"105","author":"JN Jeyapalan","year":"2011","unstructured":"Jeyapalan, J. N. et al. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance. Br. J. Cancer 105, 575\u2013585 (2011).","journal-title":"Br. J. Cancer"},{"key":"1587_CR77","doi-asserted-by":"crossref","unstructured":"Liu, C., Takada, K. & Zhu, D. Targeting Wnt\/\u03b2-catenin pathway for drug therapy. Med. Drug Discov. 8, 100066 (2020).","DOI":"10.1016\/j.medidd.2020.100066"},{"key":"1587_CR78","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.7150\/jca.93112","volume":"15","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. DPP7 as a potential therapeutic marker for colorectal cancer. J. Cancer 15, 5425\u20135439 (2024).","journal-title":"J. Cancer"},{"key":"1587_CR79","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. Integrated analysis identifies DPP7 as a prognostic biomarker in colorectal cancer. Cancers (Basel) 15, 3954 (2023).","DOI":"10.3390\/cancers15153954"},{"key":"1587_CR80","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/iub.2150","volume":"72","author":"MJ Valimaki","year":"2020","unstructured":"Valimaki, M. J. & Ruskoaho, H. J. Targeting GATA4 for cardiac repair. IUBMB Life 72, 68\u201379 (2020).","journal-title":"IUBMB Life"},{"key":"1587_CR81","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1128\/MCB.15.8.4095","volume":"15","author":"C Grepin","year":"1995","unstructured":"Grepin, C. et al. Inhibition of transcription factor GATA-4 expression blocks in vitro cardiac muscle differentiation. Mol. Cell Biol. 15, 4095\u20134102 (1995).","journal-title":"Mol. Cell Biol."},{"key":"1587_CR82","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11033-012-2085-y","volume":"40","author":"X Zhou","year":"2013","unstructured":"Zhou, X. et al. Overexpression of APRIN inhibits differentiation and proliferation and promotes apoptosis in P19 embryonal carcinoma cells. Mol. Biol. Rep. 40, 491\u2013495 (2013).","journal-title":"Mol. Biol. Rep."},{"key":"1587_CR83","doi-asserted-by":"publisher","first-page":"14882","DOI":"10.1074\/jbc.M511747200","volume":"281","author":"B Ding","year":"2006","unstructured":"Ding, B. et al. p204 is required for the differentiation of P19 murine embryonal carcinoma cells to beating cardiac myocytes: its expression is activated by the cardiac Gata4, Nkx2.5, and Tbx5 proteins. J. Biol. Chem. 281, 14882\u201314892 (2006).","journal-title":"J. Biol. Chem."},{"key":"1587_CR84","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1530\/EJE-09-0734","volume":"162","author":"J Salonen","year":"2010","unstructured":"Salonen, J. et al. Differential developmental expression of transcription factors GATA-4 and GATA-6, their cofactor FOG-2 and downstream target genes in testicular carcinoma in situ and germ cell tumors. Eur. J. Endocrinol. 162, 625\u2013631 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"1587_CR85","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.reth.2024.11.017","volume":"28","author":"MA Babu","year":"2025","unstructured":"Babu, M. A. et al. The role of GATA4 in mesenchymal stem cell senescence: A new frontier in regenerative medicine. Regen. Ther. 28, 214\u2013226 (2025).","journal-title":"Regen. Ther."},{"key":"1587_CR86","doi-asserted-by":"publisher","first-page":"120403","DOI":"10.1016\/j.cca.2025.120403","volume":"576","author":"M Pan","year":"2025","unstructured":"Pan, M. et al. Cell-free DNA methylation and its potential as a biomarker in liquid biopsy: a systematic review. Clin. Chim. Acta 576, 120403 (2025).","journal-title":"Clin. Chim. Acta"},{"key":"1587_CR87","doi-asserted-by":"publisher","first-page":"175883592210903","DOI":"10.1177\/17588359221090365","volume":"14","author":"J Krasic","year":"2022","unstructured":"Krasic, J. et al. The utility of cfDNA in TGCT patient management: a systematic review. Ther. Adv. Med. Oncol. 14, 17588359221090365 (2022).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"1587_CR88","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304.e6 (2018).","journal-title":"Cell"},{"key":"1587_CR89","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41591-023-02255-1","volume":"29","author":"D Sturm","year":"2023","unstructured":"Sturm, D. et al. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology. Nat. Med. 29, 917\u2013926 (2023).","journal-title":"Nat. Med."},{"key":"1587_CR90","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41416-023-02425-5","volume":"129","author":"F Bremmer","year":"2023","unstructured":"Bremmer, F. et al. Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets. Br. J. Cancer 129, 1580\u20131589 (2023).","journal-title":"Br. J. Cancer"},{"key":"1587_CR91","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/neuonc\/noab246","volume":"24","author":"K Satomi","year":"2022","unstructured":"Satomi, K. et al. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors. Neuro Oncol. 24, 834\u2013846 (2022).","journal-title":"Neuro Oncol."},{"key":"1587_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42842-3","volume":"13","author":"H Takami","year":"2023","unstructured":"Takami, H. et al. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors. Sci. Rep. 13, 15760 (2023).","journal-title":"Sci. Rep."},{"key":"1587_CR93","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2217\/epi-2023-0345","volume":"16","author":"M Iype","year":"2024","unstructured":"Iype, M. et al. Hypomethylation of Wnt signaling regulator genes in developmental language disorder. Epigenomics 16, 137\u2013146 (2024).","journal-title":"Epigenomics"},{"key":"1587_CR94","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1073\/pnas.1816847116","volume":"116","author":"AS Zannas","year":"2019","unstructured":"Zannas, A. S. et al. Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-kappaB-driven inflammation and cardiovascular risk. Proc. Natl. Acad. Sci. USA. 116, 11370\u201311379 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1587_CR95","doi-asserted-by":"publisher","first-page":"e70041","DOI":"10.1111\/nan.70041","volume":"51","author":"MF Euzebio","year":"2025","unstructured":"Euzebio, M. F. et al. Use of DNA methylation profiling as a molecular classification tool for paediatric central nervous system tumours: a middle-income country population-based study. Neuropathol. Appl. Neurobiol. 51, e70041 (2025).","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01587-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01587-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01587-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:19:54Z","timestamp":1781741994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01587-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01587-6","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}